Stocktoria
IN8BIO, INC. INAB
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-11-12
IN8BIO, INC. statistics & valuation
Market cap$13.4M
P / B0.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -60.2% | -145.3% | -89.0% | -86.3% | -34.7% |
| Return on equity | -70.5% | -210.2% | -120.3% | -125.5% | 38.4% |
| Current ratio | 8.82 | 4.08 | 4.57 | 3.82 | 17.28 |
Source: SEC EDGAR filings · CIK 0001740279 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.